VIRIDIAN THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.45 USD | -8.07% |
|
-3.24% | -38.25% |
| 09/05 | Oppenheimer Adjusts Viridian Therapeutics Price Target to $31 From $36, Maintains Outperform Rating | MT |
| 09/05 | B. Riley Downgrades Viridian Therapeutics to Neutral From Buy | MT |
a2491c6e27bc78337af243dbe60.ugmycytZEGu5Sl6z_1ruKQg9heQjgrSfxTCgiCpkuao.8kDCJl9gTw7-MjWE0jG9aGFetL5izIH2rm_vzUUU3_L3f-o7RxZfKv0Vag~ab3155cc0fefdab4f2c67dd1a96f5bae
